C4A and lymphoma: The clinical outcomes are in line with previous findings [29], [30] which confirm the superiority of the XGBoost in terms of sensitivity and specificity along with the importance of the C4, lymphadenopathy, and rheumatoid factor towards lymphoma prediction.